gamma-diketone peripheral neuropathy III. Neurofilament gene expression

Citation
La. Opanashuk et al., gamma-diketone peripheral neuropathy III. Neurofilament gene expression, NEUROTOXICO, 22(2), 2001, pp. 215-220
Citations number
31
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROTOXICOLOGY
ISSN journal
0161813X → ACNP
Volume
22
Issue
2
Year of publication
2001
Pages
215 - 220
Database
ISI
SICI code
0161-813X(200104)22:2<215:GPNING>2.0.ZU;2-6
Abstract
Evidence suggests the morphologic hallmark of gamma -diketone neuropathy is axon atrophy and that this effect is associated with reduced neurofilament (NF) subunit protein content (Toxicol Appl Pharmacol 2000;165:141-7). To i nvestigate the mechanism of diminished NF content, subunit (NF-L, -M and -H ) gene expression was quantified ill dorsal root ganglion (DRG) of slightly affected and moderately intoxicated groups of rats exposed to 2, 5-hexaned ione (HD) at one of three daily dosing rates (175, 250 and 400 mg/kg per da y). Results show that sensory ganglia from slightly affected rats exhibited no changes in gene expression, whereas at a moderate level of neurotoxicit y, each dosing protocol was associated with small but significant reduction s (approximately 20%) in mean NF subunit mRNA. This was nor' a generalized effect on expression of cytoskeletal components in sensory ganglia since tu bulin message levels,were not affected. Although the observed reduction in NF gene expression might be related to diminished levels of subunit protein s in peripheral nerve, the actual contribution is likely to be minimal. The magnitude of effect was small and did not correspond to the dose-rate depe ndent effect of HD on respective isotype proteins. The mechanism of gamma - diketone-induced axon atrophy is unknown but might involve local changes in axonal NF phosphorylation and degradation. (C) 2001 Elsevier Science Inc. All rights reserved.